Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy. [electronic resource] by
- Haanen, J
- Ernstoff, M S
- Wang, Y
- Menzies, A M
- Puzanov, I
- Grivas, P
- Larkin, J
- Peters, S
- Thompson, J A
- Obeid, M
Producer: 20210118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
|
5.
|
Advanced cancer patients' attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study. [electronic resource] by
- Liang, R
- Meiser, B
- Smith, S
- Kasparian, N A
- Lewis, C R
- Chin, M
- Long, G V
- Ward, R
- Menzies, A M
- Harris-Wai, J N
- Kaur, R
Producer: 20180706
In:
European journal of cancer care vol. 26
Availability: No items available.
|
|
|
6.
|
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma. [electronic resource] by
- Wilmott, J S
- Menzies, A M
- Haydu, L E
- Capper, D
- Preusser, M
- Zhang, Y E
- Thompson, J F
- Kefford, R F
- von Deimling, A
- Scolyer, R A
- Long, G V
Producer: 20130423
In:
British journal of cancer vol. 108
Availability: No items available.
|
|
|
7.
|
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. [electronic resource] by
- Pollack, M H
- Betof, A
- Dearden, H
- Rapazzo, K
- Valentine, I
- Brohl, A S
- Ancell, K K
- Long, G V
- Menzies, A M
- Eroglu, Z
- Johnson, D B
- Shoushtari, A N
Producer: 20190403
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
8.
|
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma. [electronic resource] by
- Lee, J H
- Long, G V
- Boyd, S
- Lo, S
- Menzies, A M
- Tembe, V
- Guminski, A
- Jakrot, V
- Scolyer, R A
- Mann, G J
- Kefford, R F
- Carlino, M S
- Rizos, H
Producer: 20180302
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
9.
|
Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma. [electronic resource] by
- Liniker, E
- Menzies, A M
- Kong, B Y
- Cooper, A
- Ramanujam, S
- Lo, S
- Kefford, R F
- Fogarty, G B
- Guminski, A
- Wang, T W
- Carlino, M S
- Hong, A
- Long, G V
Publication details: Oncoimmunology
In:
Oncoimmunology vol. 5
Availability: No items available.
|
|
|
10.
|
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma. [electronic resource] by
- Carlino, M S
- Haydu, L E
- Kakavand, H
- Menzies, A M
- Hamilton, A L
- Yu, B
- Ng, C C
- Cooper, W A
- Thompson, J F
- Kefford, R F
- O'Toole, S A
- Scolyer, R A
- Long, G V
Producer: 20141111
In:
British journal of cancer vol. 111
Availability: No items available.
|
|
|
11.
|
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients. [electronic resource] by
- Lee, J H
- Saw, R P
- Thompson, J F
- Lo, S
- Spillane, A J
- Shannon, K F
- Stretch, J R
- Howle, J
- Menzies, A M
- Carlino, M S
- Kefford, R F
- Long, G V
- Scolyer, R A
- Rizos, H
Producer: 20200612
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
|
12.
|
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial. [electronic resource] by
- Menzies, A M
- Ashworth, M T
- Swann, S
- Kefford, R F
- Flaherty, K
- Weber, J
- Infante, J R
- Kim, K B
- Gonzalez, R
- Hamid, O
- Schuchter, L
- Cebon, J
- Sosman, J A
- Little, S
- Sun, P
- Aktan, G
- Ouellet, D
- Jin, F
- Long, G V
- Daud, A
Producer: 20160224
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
13.
|
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. [electronic resource] by
- Menzies, A M
- Johnson, D B
- Ramanujam, S
- Atkinson, V G
- Wong, A N M
- Park, J J
- McQuade, J L
- Shoushtari, A N
- Tsai, K K
- Eroglu, Z
- Klein, O
- Hassel, J C
- Sosman, J A
- Guminski, A
- Sullivan, R J
- Ribas, A
- Carlino, M S
- Davies, M A
- Sandhu, S K
- Long, G V
Producer: 20171225
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
14.
|
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma. [electronic resource] by
- Jansen, Y J L
- Rozeman, E A
- Mason, R
- Goldinger, S M
- Geukes Foppen, M H
- Hoejberg, L
- Schmidt, H
- van Thienen, J V
- Haanen, J B A G
- Tiainen, L
- Svane, I M
- Mäkelä, S
- Seremet, T
- Arance, A
- Dummer, R
- Bastholt, L
- Nyakas, M
- Straume, O
- Menzies, A M
- Long, G V
- Atkinson, V
- Blank, C U
- Neyns, B
Producer: 20200623
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|
|
|
15.
|
Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma. [electronic resource] by
- Tetzlaff, M T
- Messina, J L
- Stein, J E
- Xu, X
- Amaria, R N
- Blank, C U
- van de Wiel, B A
- Ferguson, P M
- Rawson, R V
- Ross, M I
- Spillane, A J
- Gershenwald, J E
- Saw, R P M
- van Akkooi, A C J
- van Houdt, W J
- Mitchell, T C
- Menzies, A M
- Long, G V
- Wargo, J A
- Davies, M A
- Prieto, V G
- Taube, J M
- Scolyer, R A
Producer: 20191223
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|